Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Chronic myeloid leukemia - update 2020].
Heim D, Ebnöther M, Favre G. Heim D, et al. Among authors: ebnother m. Ther Umsch. 2019;76(9):503-509. doi: 10.1024/0040-5930/a001124. Ther Umsch. 2019. PMID: 32157969 Review. German.
G-CSF for imatinib-induced neutropenia.
Heim D, Ebnöther M, Meyer-Monard S, Tsakiris D, Linn M, Tichelli A, Gratwohl A. Heim D, et al. Among authors: ebnother m. Leukemia. 2003 Apr;17(4):805-7. doi: 10.1038/sj.leu.2402869. Leukemia. 2003. PMID: 12682643 No abstract available.
BRAF inhibitor treatment in classic hairy cell leukemia: a long-term follow-up study of patients treated outside clinical trials.
Liebers N, Roider T, Bohn JP, Haberbosch I, Pircher A, Ferstl B, Ebnöther M, Wendtner CM, Dearden C, Follows GA, Ho AD, Müller-Tidow C, Dreger P, Troussard X, Zenz T, Dietrich S. Liebers N, et al. Among authors: ebnother m. Leukemia. 2020 May;34(5):1454-1457. doi: 10.1038/s41375-019-0646-y. Epub 2019 Nov 18. Leukemia. 2020. PMID: 31740808 No abstract available.
Congenital dyserythropoietic anemia type I (CDA I): molecular genetics, clinical appearance, and prognosis based on long-term observation.
Heimpel H, Schwarz K, Ebnöther M, Goede JS, Heydrich D, Kamp T, Plaumann L, Rath B, Roessler J, Schildknecht O, Schmid M, Wuillemin W, Einsiedler B, Leichtle R, Tamary H, Kohne E. Heimpel H, et al. Among authors: ebnother m. Blood. 2006 Jan 1;107(1):334-40. doi: 10.1182/blood-2005-01-0421. Epub 2005 Sep 1. Blood. 2006. PMID: 16141353 Free article.
[Lymphadenopathy and diabetes insipidus - association].
Zahnd R, Oestmann A, Ebnöther M. Zahnd R, et al. Among authors: ebnother m. Praxis (Bern 1994). 2010 Mar 17;99(6):381-4. doi: 10.1024/1661-8157/a000081. Praxis (Bern 1994). 2010. PMID: 20235031 German.
Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland.
Moccia AA, Aeppli S, Güsewell S, Bargetzi M, Caspar C, Brülisauer D, Ebnöther M, Fehr M, Fischer N, Ghilardi G, Krasniqi F, Lang N, Mey U, Mingrone W, Novak U, Pfleger C, Richter P, Rütti M, Schmidt A, Stenner F, Voegeli M, Zander T, Zucca E, Hitz F. Moccia AA, et al. Among authors: ebnother m. Hematol Oncol. 2021 Apr;39(2):196-204. doi: 10.1002/hon.2830. Epub 2020 Dec 23. Hematol Oncol. 2021. PMID: 33300135
SDHA gain-of-function engages inflammatory mitochondrial retrograde signaling via KEAP1-Nrf2.
Burgener AV, Bantug GR, Meyer BJ, Higgins R, Ghosh A, Bignucolo O, Ma EH, Loeliger J, Unterstab G, Geigges M, Steiner R, Enamorado M, Ivanek R, Hunziker D, Schmidt A, Müller-Durovic B, Grählert J, Epple R, Dimeloe S, Lötscher J, Sauder U, Ebnöther M, Burger B, Heijnen I, Martínez-Cano S, Cantoni N, Brücker R, Kahlert CR, Sancho D, Jones RG, Navarini A, Recher M, Hess C. Burgener AV, et al. Among authors: ebnother m. Nat Immunol. 2019 Oct;20(10):1311-1321. doi: 10.1038/s41590-019-0482-2. Epub 2019 Sep 16. Nat Immunol. 2019. PMID: 31527833
15 results